Targis System - Benign Prostatic Hyperplasia or BPH Treatment
The Targis System is comprised of:
- a Control Unit (CoolWave® Control Unit or Targis® Control Unit)
- a Microwave Catheter (CTC Advance® Microwave Catheter or Targis® Microwave Catheter)
- a Rectal Thermal Sensing Unit (RTU)
- a Coolant Bag
Control units produce microwave energy and monitor the Cooled ThermoTherapy™ procedure. Our Microwave Catheters deliver microwave energy to the targeted prostatic tissue. The RTU measures rectal temperatures during the Cooled ThermoTherapy procedure. The Coolant Bag provides a reservoir of sterile coolant water to the Microwave Catheter.
Cooled ThermoTherapy
Optimal durability and enhanced patient comfort
The Targis® System uses Cooled ThermoTherapy (transurethral microwave thermotherapy - TUMT) to deliver precisely targeted microwave energy deep into hyperplastic prostate tissue creating coagulative necrosis for durable1 clinical outcomes.
- Multiple parameter feedback system continually monitors urethral and rectal temperatures for optimal therapeutic intraprostatic temperatures
- Cooling enhances patient comfort and quick recovery times
- Drainage lumen in catheter and soft coudé tip enhance patient comfort
The Targis® is a versatile, precise, customizable BPH treatment.
The Cooled ThermoTherapy treatment provides optimal flexibility to customize treatment based on individual patient’s needs:
- Patented microwave antenna design for deep symmetrical prostatic heating
- Enhanced software capabilities allow for customization during treatment for each patient
- Treatment time can be adjusted: 28.5 to 60 minutes
- User-friendly operation for quick and simple benign prostatic hyperplasia treatment
1Miller, Paul D., et al, Cooled ThermoTherapy for the Treatment of Benign Prostatic Hyperplasia: Durability of Results Obtained with the Targis System, Urology, Vol. 61, No. 6, June 2003.
Control Units
CoolWave Control Unit
The CoolWave Control Unit refines and advances the delivery of Cooled ThermoTherapy by enabling the physician to tailor cooled, variable-energy microwave treatment for patients. Now you can achieve safe, durable results1 with a minimally invasive Control Unit that offers the ability to customize each treatment based on individual patient need.
Customizable BPH Treatments
- Control urethral temperature, urethral coolant temperature, treatment ramp-rate and treatment time*
- Optimize energy delivered during the treatment
- Customize the treatment to meet your patients' needs
Easy to Use
- Utilize intuitive controls to modify treatment parameters during each procedure
- New high resolution touch screen for visual treatment feedback and monitoring, including total energy delivered (kJ) during treatment
- On screen help resources for you and your staff
- Choose between standard and custom protocols
- Radio Frequency Identification (RFID) technology enables the CoolWave Control Unit to wirelessly identify treatment catheters, saving valuable time during set-up
Enhanced Patient Management
- Generates detailed patient treatment files
- Treatment files provide important documentation for patient files and for correspondence with referring physicians
Ordering
To Place an Order, Call Customer Service Today 1.888.229.0772
|
Product Description |
Ordering Number |
|
CoolWave Control Unit |
400009-001 |
|
CoolWave Control Unit (Refurbished) |
400009-003 |
Targis System Control Unit
For more than a decade, the Targis System Control Unit has been instrumental in delivering Cooled ThermoTherapy at urologists’ offices across the country.
The Targis System Control Unit offers:
- Cooling technology
- Deep heat penetration
- Customizable treatment protocols
If you have questions about your Targis Control Unit, or would like to learn more about our New! CoolWave Control Unit - Please call 1-888-4-BPH-HLP.
1Miller, Paul D., et al, Cooled ThermoTherapy for the Treatment of Benign Prostatic Hyperplasia: Durability of Results Obtained with the Targis System, Urology, Vol. 61. No. 6, June 2003.
*Treatment duration for Cooled ThermoCath® Microwave Catheters is 28.5 minutes. BPH Treatment duration for Targis® Microwave Catheters is 28.5 or 60 minutes.
Microwave Catheters
CTC Advance® Microwave Catheter
More Cooling. Greater Flexibly. Same Durable Results.
50% more cooling*The CTC Advance Microwave Catheter has additional surface cooling proximal to the catheter’s treatment zone. The advanced cooling is designed to further protect the tissue at the periphery of the treatment area and to enhance comfort for the patient.3
72% more flexible**The CTC Advance Microwave Catheter is designed for easier insertion with increased flexibility in the treatment area. This new design also features a slightly longer working length to better accommodate anatomical variations.
Same DurabilityWith over 225,000 patients treated and 120 published articles, Cooled ThermoTherapy has proved to be a long-lasting solution for BPH.3-5 |
 |
*50% more cooled surface area proximal to the treatment area compared to the CTC Microwave Catheter. Data on file at Urologix, Inc.
**72% greater flexibility of the catheter treatment area compared to the CTC Microwave Catheter. Data on file at Urologix, Inc.
Cooled ThermoCath
The Cooled ThermoCath (CTC) family of microwave catheters provides durable1 BPH treatments for patients with medium to large prostatic urethral lengths (≥3.0), medium to large glands2 and obstructive BPH. With CTC, you can treat patients with glands of up to 100 cc.
Enhanced cooling coupled with higher energy output allows the generation of greater intraprostatic tissue temperatures in a shorter amount of time, while maintaining patient comfort. Treatment time with Cooled ThermoCath microwave catheters is just 28.5 minutes.
Cooled ThermoCath (Regular)
|
 |
Cooled ThermoCath (Long)
|
 |
Targis Microwave Catheter
Effective and Comfortable BPH Treatment for Small to Medium Glands
When combined with a physician optimized Cooled ThermoTherapy control unit, the Targis catheter family permits you to produce the lasting results your patients demand while providing the comfort they expect.
Treatment with the Targis catheter family provides an effective 28.5 minute treatment option for patients with small to medium prostatic urethral lengths (2.5 - 5.0 cm) and small to medium glands2, with symptomatic to obstructive BPH.
Targis catheter treatments can also be customized for effective and long-lasting treatment for patients who have medium to large prostatic urethral lengths as well as large glands2.
Targis (Regular)
|
 |
Targis (Short)
|
 |
1Miller, Paul D., et al, Cooled ThermoTherapy for the Treatment of Benign Prostatic Hyperplasia: Durability of Results Obtained with the Targis System, Urology, Vol. 61. No. 6, June 2003.
2Mynderse, Lance A., et al, Cooled ThermoTherapy from Urologix: BPH Treatment of Choice for Drs. James and Goldberg of the Mankato Clinic, MC1357 Rev A., 03/07.
3Data on file at Urologix, Inc.
4Miller, PD, Kastner C, Ramsey EW, Parsons K, Cooled Thermotherapy for the treatment of benign prostatic hyperplasia: durability of results obtained with the Targis System. Urology. 2003;611(6):1160-1164.
5MC1475 Rev A 05/08 Mynderse LA, et al, Continuing Results of a multi-center trial of a new generation TUMT for BPH, Moderated poster session #66 / abstract 1969, presented at: American Urological Association Annual Meeting; 2008 May 17-22; Orlando, FL.
RTU
Patient Safety, Comfort and Ease of Use
Safety
- Five thermosensors relay vital data to software algorithms that regulate treatment and visually display information on the Control Unit
- Balloon designed for placement and position on rectal wall
Comfort
- Soft balloon design conforms to the patient's anatomy
- Small profile designed for easy insertion
Easy to Use
- Narrow diameter for easy insertion and orientation
- Disposable, one-time use sheath
Ordering
To Place an Order, Call Customer Service Today 1.888.229.0772
|
Product Description |
Ordering Number |
|
RTU+ Handle |
410063-002 |
|
RTU+ Handle (3 Pack) |
410063-005 |
Coolant Bag
The Coolant Bag provides a reservoir of sterile coolant water to the Microwave Catheter.
Prescriptive Information
Indications:
The Targis® System is a non-surgical device intended to relieve symptoms and obstruction associated with Benign Prostatic Hyperplasia (BPH).
Targis System Description:
The Targis System is comprised of a Control Unit which produces the microwave energy and monitors all aspects of the Cooled ThermoTherapy procedure, a Microwave Catheter which delivers the microwave energy to the targeted prostatic tissue, an RTU which measures rectal temperatures during the Cooled ThermoTherapy procedure and a Coolant Bag which provides a reservoir of sterile coolant water to the Microwave Catheter. The Targis System treats BPH by applying microwave power to the prostate, and continuously heating the diseased tissue via transurethral catheter. It also minimizes patient discomfort and risk to the urethra by circulating cooling fluid through the Microwave Catheter.
Contraindications:
Patients with a prostatic urethra <2.5 cm in length, measured from the bladder neck to the verumontanum. Patients with urinary sphincter or any implant (metallic or non-metallic) which is within 1.5 inches (38 mm) of the prostatic urethra. Patients with urethral stricture (unable to pass 22 F urethroscope). Patients with peripheral arterial disease with intermittent claudication or Leriches Syndrome (i.e. claudication of the buttocks or perineum). Patients who have undergone pelvic radiation therapy. Patients with implanted active devices, including pacemakers or defibrillators, within 2.6 inches (6.5 cm) of the prostatic urethra. For patients with active implanted devices located greater than 2.6 inches (6.5 cm) from the prostatic urethra, it is recommended that non-cardiac devices be turned OFF during treatment with the Targis system, if possible(e.g. active implanted devices used in the treatment of pain or incontinence), to lessen the likelihood of adverse interaction caused by electromagnetic interference.
Warnings & Precautions
Only those physicians who have been thoroughly trained on the operation of the Targis System and the Cooled ThermoTherapy procedure should deliver the Cooled ThermoTherapy procedure. The Targis System and components should not be used in any way other than the intended and indicated use and according to the Instructions for Use. The Cooled ThermoTherapy procedure must not be initiated without assurance that the Microwave Catheter is properly positioned in the patient. The Cooled ThermoTherapy procedure must not be initiated until an enema has been given and the RTU is properly placed into the patient’s rectum and inflated. It is important that the patient not be over sedated. This may compromise his ability to communicate pain. All components of the Targis System must be used in a manner consistent with the instructions set forth in their respective Instructions for Use insert and the Targis System User Manual. Failure to do so may result in insufficient treatment or increased risk of injury or infection to the patient.
Potential Adverse Effects
The following complications have been observed: post-treatment catheterization, mild hematuria, dysuria, clots in urine, temporary or partial ejaculate loss, pain or irritation in the groin or pelvis, bladder spasms, hemospermia, prostatic urethra damage, rectal irritation, temporary acute incontinence, interrupted flow, sensation of not emptying bladder, bladder trabeculation, severe pain during treatment, pain or discomfort during sexual activity, frequency, hesitancy, urgency, post-void dribbling, blood pressure changes during treatment, hospitalization in general related to treatment, transient erectile dysfunction, urinary tract infection, complete loss of ejaculate, bladder diverticali, weak stream, erectile dysfunction, epididymitis, prostatitis, nocturia, urethral stricture, and rectal fistula.
Caution: Federal (U.S.A.) law restricts this device to sale by or on the order of a physician.
View the complete Instructions for Use by selecting the Product Downloads tab on this page.
